CDC's Grand Rounds Presents “Multidrug-resistant Tuberculosis: New Tools to Tackle New Challenges from an Old Foe,” on Tuesday, March 18, at 1 p.m. (EDT).

We are pleased to present the March session of CDC’s Public Health Grand Rounds, “Multidrug-resistant Tuberculosis: New Tools to Tackle New Challenges from an Old Foe.” This session will be available via live webcast from CDC headquarters in Atlanta, Georgia on Tuesday, March 18 at 1 p.m. (EDT) athttp://www.cdc.gov/about/grand-rounds/.

Tuberculosis is an ancient disease that remains an important global cause of morbidity and mortality. In most cases, TB can be treated and cured by taking a combination of several drugs for 6 to 12 months. When inappropriate or incomplete treatment takes place, however, TB bacteria can develop resistance to multiple drugs. Treatment of drug-resistant TB is currently longer, more toxic, more complex, and less effective than for drug-susceptible TB. In 2011, less than 10% of the total estimated multidrug-resistant TB (MDR TB) cases were detected and annually, there are approximately 500,000 cases of MDR TB, and 150,000 deaths. Although there are simple rapid tests that have improved the diagnosis of the disease, there is immense potential to increase the number of persons diagnosed with MDR TB, and diagnose them more quickly so that they can begin treatment sooner.

Please join us as we discuss how more patients can benefit from advances in diagnostic and treatment options, resulting in an overall reduction in morbidity from MDR TB. This session of Grand Rounds will also explore the role of CDC, WHO and other partners in combating this public health epidemic.

Future Grand Rounds topics include autism and PrEP for Prevention of HIV.

Email your questions about this topic before or during the session. Follow us on Twitter #cdcgrandrounds

Presented By:

Sarita Shah, MD, MPH

Associate Chief for Science, International Research and Programs Branch, Division of TB Elimination 

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC 

“The Public Health Importance of Drug-resistant Tuberculosis”

Tom Shinnick, PhD

Associate Director for Global Laboratory Activities, Division of TB Elimination 

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC 

“Rapid Diagnosis of MDR TB: A Laboratory Systems-based Approach”

Christian Lienhardt, MD, DTM, MSc, PhD 

Senior Research Advisor, Stop TB Department,

World Health Organization, Geneva, Switzerland 

“Rational Use of New Drugs for Treatment of MDR TB: Context and Challenges”

Tom Kenyon, MD, MPH

Director, Center for Global Health, CDC 

“Drug Resistance in TB: What Public Health Can Do Now and in the Future”

Facilitated By:

John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds 

Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds

For non-CDC staff or those outside of the CDC firewall:

A live external webcast will be available. Presentations are archived and posted 48 hours after each session. Due to security measures at CDC’s Roybal campus, non-CDC staff who wish to attend these sessions in person must have prior clearance and a U.S. state-issued photo ID (e.g., driver’s license, U.S. passport).

Names of non-CDC staff (both domestic and international) should be submitted to the Grand Rounds Team.Please note that all information for international visitors must be submitted at least 10 days in advance.

For CDC staff requiring reasonable accommodations:

It is the policy of CDC to provide reasonable accommodations (RA) for qualified individuals with disabilities to ensure their full inclusion in CDC-sponsored training events.  Employees are asked to submit RA requests at least two weeks prior to the training event.  Please e-mail the request to grandrounds@cdc.gov.

Grand Rounds is available for Continuing Education.

ALL Continuing Education hours for PHGR are issued online through the CDC/ATSDR Training and Continuing Education Online system. If you have questions, e-mail or call Learner Support at1-800-418-7246 (1-800-41TRAIN).

Those who attend PHGR either in person, Envision, IPTV, or “web on demand” and who wish to receive continuing education must complete the online seminar evaluation. Thirty days from the initial seminar the course number will change to WD2346 and will be available for continuing education until February 18, 2016.  The course code for PHGR is PHGR10.

Target Audience: Physicians, nurses, epidemiologists, pharmacists, veterinarians, certified health education specialists, laboratorians, others

Objectives:

1. List key measures of burden of disease involving morbidity, mortality, and/or cost.
2. Describe evidence-based preventive interventions and the status of their implementations.
3. Identify one key prevention science research gap.
4. Name one key indicator by which progress and meeting prevention goals is measured.

CE certificates can be printed from your computer immediately upon completion of your online evaluation. A cumulative transcript of all CDC/ATSDR CE’s obtained through the TCE Online System will be maintained for each user. We hope that this will assist CDC staff and other public health professionals to fulfill the requirements for their professional licenses and certificates.

Learn more about continuing education on the Grand Rounds website.